NEW YORK, Aug. 9, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
Month: August 2024
NEW YORK, Aug. 9, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext….
NEW YORK, Aug. 9, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of W. P. Carey Inc. (“W. P. Carey” or the “Company”) (NYSE: WPC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, Aug. 9, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of ZoomInfo Technologies Inc. (“ZoomInfo” or the “Company”) (NASDAQ: ZI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Aug. 9, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Paragon 28, Inc. (“Paragon 28” or the “Company”) (NYSE: FNA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, Aug. 9, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Customers Bancorp, Inc (“Customers Bancorp” or the “Company”) (NYSE: CUBI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Aug. 9, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Helen of Troy Ltd. (“Helen of Troy” or the “Company”) (NASDAQ: HELE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Aug. 9, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Enfusion, Inc. (“Enfusion” or the “Company”) (NYSE: ENFN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, Aug. 9, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Chegg, Inc. (“Chegg” or the “Company”) (NYSE: CHGG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns…
NEW YORK, Aug. 9, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Actinium Pharmaceuticals, Inc. (“Actinium” or the “Company”) (NYSE: ATNM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…